KilerFLIP-E

General Information


DRACP ID  DRACP00477

Peptide Name   KilerFLIP-E

Sequence  YGRKKRRQRRRREADFFWSLCTA

Sequence Length  23

UniProt ID  Not available

PubChem CID  Not available

Origin  The C-terminal domain of c-FLIP

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
K562 Blast phase chronic myelogenous leukemia, BCR-ABL1 positive; Chronic myeloid leukemia Leukemia At 20 μM, 7.7% Trypan blue-negative cells Trypan blue assay 18 h 1
MV4-11 Childhood acute monocytic leukemia; Acute monoblastic/monocytic leukemia Leukemia At 20 μM, 10.8% Trypan blue-negative cells Trypan blue assay 18 h 1
RS4;11 Adult B acute lymphoblastic leukemia; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3) Leukemia At 20 μM, 10.4% Trypan blue-negative cells Trypan blue assay 18 h 1
PC-3 Prostate carcinoma Carcinoma At 20 μM, about 50% Trypan blue-negative cells Trypan blue assay 18 h 1
PC-3-TR Prostate carcinoma Carcinoma At 20 μM, about 30% Trypan blue-negative cells Trypan blue assay 18 h 1
LNCaP Prostate carcinoma Carcinoma At 20 μM, about 30% Trypan blue-negative cells Trypan blue assay 18 h 1
HCT 116 Colon carcinoma Carcinoma At 20 μM, about 70% Trypan blue-negative cells Trypan blue assay 18 h 1
HCT 115 Human colon cancer Carcinoma At 20 μM, 40% Trypan blue-negative cells Trypan blue assay 18 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  No toxicity was observed in epithelial and endothelial cells (HPDE and HUVEC, respectively)

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00477

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C130H208N48O32S

Absent amino acids  HIMNPV

Common amino acids  R

Mass  338001

Pl  12.13

Basic residues  9

Acidic residues  2

Hydrophobic residues  6

Net charge  7

Boman Index  -12367

Hydrophobicity  -166.96

Aliphatic Index  25.65

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  6990

Absorbance 280nm  317.73

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24176852

Title  killerFLIP: a novel lytic peptide specifically inducing cancer cell death

Doi 10.1038/cddis.2013.401

Year  2013

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.